Brigham and Women's Hospital
75 Francis Street
Boston
Massachusetts
02115
Tel: 617-732-5500
Website: http://www.brighamandwomens.org/
About Brigham and Women's Hospital
Brigham and Women's Hospital is home for one of the most powerful Biomedical Research Institutes in the world. Over 500 scientists and $240 million in research grants are committed to bringing the latest advances in medical care and basic science to the BWH.Research Departments include:
Last Updated 8-24-01
330 articles with Brigham and Women's Hospital
-
Scientists found that SARS-CoV-2 spike protein in the plasma could be a hallmark of long COVID, suggesting that the virus can linger in the body who suffer from prolonged symptoms.
-
Researchers have been able to use machine learning to evaluate MRI scans and diagnose Alzheimer's in a single scan. For that and more research news, continue reading.
-
Despite the refutation of research articles by Piero Anversa, they continue to serve as a basis for funding requests from scientists who hope to prove that the heart can regenerate cardiac muscle.
-
Calls for a reform of drug prices have become a regular occurrence, particularly in the midst of political campaigns. Yet a new report shows the median price of a new drug launched in 2021 was $180,000.
-
PANCRYOS ANNOUNCES EXCLUSIVE GLOBAL LICENSE AGREEMENT FOR FIRST IN CLASS MACROENCAPSULATION DEVICE
5/24/2022
Pancryos today announced that it has executed a global exclusive license with Brigham and Women's Hospital for the first in class convection-enhanced macroencapsulation device.
-
At the Brigham and Women's Hospital, a male patient with Secondary Progressive Multiple Sclerosis serves as a beacon of hope for those afflicted with the same neurodegenerative disease.
-
WRNMC researchers have found a way to create a vaccine that can recognize multiple spike proteins at once by using ferritin. Here's more about pan coronavirus vaccine.
-
After receiving daily doses of the therapeutic, 71% of the children could tolerate the equivalent of 16 peanuts and six months later, 21% of them still could.
-
Tiziana Enrolls Second Patient in Ongoing Intranasal Foralumab Evaluation for Secondary Progressive Multiple Sclerosis
1/10/2022
Tiziana Life Sciences is pleased to announce that the U.S. Food and Drug Administration allowed enrollment of a second patient in the ongoing clinical treatment of secondary progressive multiple sclerosis with intranasally administered foralumab, a fully human anti-CD3 monoclonal antibody, at the Brigham and Women’s Hospital, Harvard University, Boston, MA.
-
Scientists from Brigham and Women's Hospital are ready to start a clinical trial that will evaluate the use of an intranasal vaccine to prevent Alzheimer's disease.
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Sirtex Medical provides donations to Massachusetts Institute of Technology (MIT) and Brigham and Women's Hospital in support of the Artzi Lab, as part of Sirtex's corporate citizenship strategy to support research and innovation
6/8/2021
Sirtex Medical, a leading manufacturer of targeted liver cancer therapies, has provided grants to Massachusetts Institute of Technology and Brigham and Women's Hospital for the advancement of cancer treatment, to be shared with the independent Artzi Lab.
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
MNA Brigham and Women's Hospital Nurses Urge Executives to Use Stronger Safety Measures to Properly Contain Ongoing COVID-19 Cluster
9/28/2020
The 3,400 registered nurses of Brigham and Women's Hospital, represented by the Massachusetts Nurses Association, have decided to take public their concerns about how the hospital is hand
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 31, 2020.
-
Clinical Catch-Up: May 18-22
5/26/2020
Non-COVID-19 clinical trial updates are outweighing COVID-19 studies, particularly with the American Society of Clinical Oncology meeting coming up soon. Here’s a look. -
Large International Study of Chloroquine for COVID-19 Shows No Benefit and Significant Harm
5/22/2020
The study found that of the 15,000 patients who received either of the drugs were almost twice as likely to die compared to the patients who did not receive them. The research was published in the journal The Lancet.